Drug Type Small molecule drug |
Synonyms AST2169脂质体, AST-NS2101, AST2169 + [1] |
Target |
Mechanism KRAS G12D inhibitors(GTPase KRas G12D inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
KRAS G12D mutation Solid Tumors | Phase 1 | CN | 28 Jun 2024 | |
Colorectal Cancer | IND Application | CN | 01 Nov 2024 | |
Non-Small Cell Lung Cancer | IND Application | CN | 01 Nov 2024 | |
Pancreatic Cancer | IND Application | CN | 01 Nov 2024 |